FULLER H B CO Segments Disclosure
Note 15: Segments
We are required to report segment information in the same way that we internally organize our business for assessing performance and making decisions regarding allocation of resources. Revenue and Adjusted EBITDA of each of our segments are regularly reviewed by our chief executive officer, who acts as our chief operating decision maker, to make decisions about resources to be allocated to the segments and assess their performance. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation and amortization and foreign currency gain/loss, adjusted for other items within a relevant period which are not reflective of the segment’s operating performance in the period. Corporate expenses, other than those included in Corporate Unallocated, are allocated to each operating segment. Consistent with our internal management reporting, Corporate Unallocated includes and Adjusted EBITDA excludes amounts related to business acquisition and integration costs, organizational restructuring charges and project costs associated with our implementation of Project ONE. Corporate assets are not allocated to the operating segments. Inter-segment revenues are recorded at cost plus a markup for administrative costs.
As of November 30, 2024, our operating segments consisted of Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. As of the beginning of fiscal 2025, we reorganized our operating segments by selling our North America Flooring business, previously part of the Construction Adhesives operating segment, and combining our Insulated Glass, Woodworking and Composite businesses, previously part of the Engineering Adhesives operating segment, with Construction Adhesives Roofing and Building Envelope and Infrastructure businesses to form the Building Adhesive Solutions operating segment. All financial results related to North America Flooring have been moved to our Corporate Unallocated segment. Prior period segment information has been recast retrospectively to reflect the realignment.
The business components within each operating segment are managed to maximize the results of the overall operating segment rather than the results of any individual business component of the operating segment. Results of individual components of each operating segment are subject to numerous allocations of segment-wide costs that may or may not have been focused on that particular component for a particular reporting period. The costs for these allocated resources are not tracked on a “where-used” basis as financial performance is assessed at the total operating segment level.
Reportable operating segment financial information for all periods presented is as follows:
| Hygiene, Health | Building | |||||||||||||||||||||||
| Year Ended | and Consumable | Engineering | Adhesive | Corporate | H.B. Fuller | |||||||||||||||||||
| November 29, 2025 | Adhesives | Adhesives | Solutions | Total | Unallocated | Consolidated | ||||||||||||||||||
| Net revenue | $ | 1,551,789 | $ | 1,061,779 | $ | 860,021 | $ | 3,473,589 | $ | - | $ | 3,473,589 | ||||||||||||
| Segment expenses and other items 1 | 1,307,408 | 825,810 | 726,008 | 2,859,226 | (6,297 | ) | 2,852,929 | |||||||||||||||||
| Adjusted EBITDA | $ | 244,381 | $ | 235,969 | $ | 134,013 | $ | 614,363 | $ | 6,297 | $ | 620,660 | ||||||||||||
| Depreciation and amortization | $ | 64,423 | $ | 61,794 | $ | 51,507 | $ | 177,724 | $ | 596 | $ | 178,320 | ||||||||||||
| Total Assets | 1,963,357 | 1,566,264 | 1,188,916 | 4,718,537 | 464,169 | 5,182,706 | ||||||||||||||||||
| Capital Expenditure | 24,059 | 23,945 | 18,438 | 66,442 | 75,833 | 142,275 | ||||||||||||||||||
| Hygiene, Health | Building | |||||||||||||||||||||||
| Year Ended | and Consumable | Engineering | Adhesive | Corporate | H.B. Fuller | |||||||||||||||||||
| November 30, 2024 | Adhesives | Adhesives | Solutions | Total | Unallocated | Consolidated | ||||||||||||||||||
| Net revenue | $ | 1,546,545 | $ | 1,009,031 | $ | 856,503 | $ | 3,412,079 | $ | 156,657 | $ | 3,568,736 | ||||||||||||
| Segment expenses and other items 1 | 1,300,795 | 808,519 | 723,332 | 2,832,646 | 142,235 | 2,974,881 | ||||||||||||||||||
| Adjusted EBITDA | $ | 245,750 | $ | 200,512 | $ | 133,171 | $ | 579,433 | $ | 14,422 | $ | 593,855 | ||||||||||||
| Depreciation and amortization | $ | 55,029 | $ | 53,402 | $ | 49,919 | $ | 158,350 | $ | 16,360 | $ | 174,710 | ||||||||||||
| Total Assets | 1,610,902 | 1,533,675 | 1,239,527 | 4,384,104 | 549,140 | 4,933,244 | ||||||||||||||||||
| Capital Expenditure | 26,271 | 18,379 | 36,713 | 81,363 | 57,875 | 139,238 | ||||||||||||||||||
| Hygiene, Health | Building | |||||||||||||||||||||||
| Year Ended | and Consumable | Engineering | Adhesive | Corporate | H.B. Fuller | |||||||||||||||||||
| December 2, 2023 | Adhesives | Adhesives | Solutions | Total | Unallocated | Consolidated | ||||||||||||||||||
| Net revenue | $ | 1,607,607 | $ | 973,012 | $ | 777,518 | $ | 3,358,137 | $ | 152,797 | $ | 3,510,934 | ||||||||||||
| Segment expenses and other items 1 | 1,328,533 | 783,637 | 670,465 | 2,782,635 | 147,461 | 2,930,096 | ||||||||||||||||||
| Adjusted EBITDA | $ | 279,074 | $ | 189,375 | $ | 107,053 | $ | 575,502 | $ | 5,336 | $ | 580,838 | ||||||||||||
| Depreciation and amortization | $ | 51,204 | $ | 41,464 | $ | 56,004 | $ | 148,672 | $ | 11,169 | $ | 159,841 | ||||||||||||
1 Segment expenses and other items for all segments primarily include raw material costs, compensation and benefits, delivery expense, rent and lease expense, professional services, travel and entertainment, repairs and maintenance and other manufacturing overhead.
We use both GAAP and non-GAAP financial measures, including Adjusted EBITDA, for operational and financial decision making, and to assess Company and segment business performance. Adjusted EBITDA is not a measurement of financial performance under U.S. GAAP. Our calculation of this non-GAAP measure may not be comparable to similarly titled measures of other companies due to potential differences between companies in the method of calculation. As a result, the use of this non-GAAP measure has limitations and should not be considered superior to, in isolation from, or as a substitute for, related U.S. GAAP measures. The following table provides a reconciliation of the Company’s Adjusted EBITDA to net income attributable to H.B. Fuller for the years ended November 29, 2025, November 30, 2024 and December 2, 2023:
Reconciliation of Net income attributable to H.B. Fuller to Adjusted EBITDA
| Year Ended | ||||||||||||
| November 29, | November 30, | December 2, | ||||||||||
| 2025 | 2024 | 2023 | ||||||||||
| Net income attributable to H.B. Fuller | $ | 151,967 | 130,256 | 144,906 | ||||||||
| Adjustments: | ||||||||||||
| Acquisition project costs | 15,412 | 11,035 | 16,874 | |||||||||
| Organizational realignment | 31,424 | 39,996 | 29,900 | |||||||||
| Project One | 10,237 | 11,885 | 9,815 | |||||||||
| Business divestiture | - | 47,267 | - | |||||||||
| Other1 | 39,155 | (1,981 | ) | (611 | ) | |||||||
| Discrete tax items | 7,467 | (5,469 | ) | 26,085 | ||||||||
| Income tax effect on adjustments | (21,054 | ) | (15,811 | ) | (10,604 | ) | ||||||
| Adjusted net income attributable to H.B. Fuller | 234,608 | 217,178 | 216,365 | |||||||||
| Add: | ||||||||||||
| Interest expense2 | 132,431 | 133,122 | 131,913 | |||||||||
| Interest income | (4,820 | ) | (4,679 | ) | (3,943 | ) | ||||||
| Income taxes | 80,717 | 77,661 | 78,047 | |||||||||
| Depreciation and amortization expense3 | 177,724 | 170,573 | 158,456 | |||||||||
| Adjusted EBITDA | 620,660 | 593,855 | 580,838 | |||||||||
1 Other includes losses associated with ongoing litigation and product claims related to a divested business and costs associated with the exit of a product line for the year ended November 29, 2025.
2 Interest expense added back for EBITDA is adjusted for amounts already included in adjusted net income attributable to H.B. Fuller.
3 Depreciation and amortization expense added back for EBITDA is adjusted for amounts already included in adjusted net income attributable to H.B. Fuller.
Financial information about geographic areas
| Net Revenue | ||||||||||||
| 2025 | 2024 | 2023 | ||||||||||
| United States | $ | 1,521,418 | $ | 1,623,854 | $ | 1,551,846 | ||||||
| China | 447,066 | 438,512 | 430,948 | |||||||||
| Germany | 352,447 | 362,919 | 393,029 | |||||||||
| Countries with more than 10 percent of total | 2,320,931 | 2,425,285 | 2,375,823 | |||||||||
| All other countries with less than 10 percent of total | 1,152,658 | 1,143,451 | 1,135,111 | |||||||||
| Total | $ | 3,473,589 | $ | 3,568,736 | $ | 3,510,934 | ||||||
| Property, Plant and Equipment, net | ||||||||||||
| 2025 | 2024 | 2023 | ||||||||||
| United States | $ | 523,282 | $ | 472,084 | $ | 425,765 | ||||||
| China | 109,751 | 109,665 | 110,061 | |||||||||
| Germany | 101,666 | 98,233 | 114,266 | |||||||||
| All other countries with less than 10 percent of total | 200,562 | 201,945 | 174,563 | |||||||||
| Total | $ | 935,261 | $ | 881,927 | $ | 824,655 | ||||||
We view the following disaggregation of net revenue by geographic region as useful to understanding the composition of revenue recognized during the respective reporting periods:
| November 29, 2025 | ||||||||||||||||||||
| Hygiene, Health and Consumable | Engineering | Building Adhesive | Corporate | |||||||||||||||||
| Adhesives | Adhesives | Solutions | Unallocated | Total | ||||||||||||||||
| Americas | $ | 867,316 | $ | 449,607 | $ | 465,363 | $ | - | $ | 1,782,286 | ||||||||||
| EIMEA | 476,718 | 235,544 | 334,343 | - | 1,046,605 | |||||||||||||||
| Asia Pacific | 207,755 | 376,628 | 60,315 | - | 644,698 | |||||||||||||||
| $ | 1,551,789 | $ | 1,061,779 | $ | 860,021 | $ | - | $ | 3,473,589 | |||||||||||
| November 30, 2024 | ||||||||||||||||||||
| Hygiene, Health and Consumable | Engineering | Building Adhesive | Corporate | |||||||||||||||||
| Adhesives | Adhesives | Solutions | Unallocated | Total | ||||||||||||||||
| Americas | $ | 884,512 | $ | 414,568 | $ | 455,280 | $ | 156,657 | $ | 1,911,017 | ||||||||||
| EIMEA | 454,336 | 233,560 | 338,273 | - | 1,026,169 | |||||||||||||||
| Asia Pacific | 207,697 | 360,903 | 62,950 | - | 631,550 | |||||||||||||||
| $ | 1,546,545 | $ | 1,009,031 | $ | 856,503 | $ | 156,657 | $ | 3,568,736 | |||||||||||
| December 2, 2023 | ||||||||||||||||||||
| Hygiene, Health and Consumable | Engineering | Building Adhesive | Corporate | |||||||||||||||||
| Adhesives | Adhesives | Solutions | Unallocated | Total | ||||||||||||||||
| Americas | $ | 921,934 | $ | 379,488 | $ | 406,647 | $ | 152,797 | $ | 1,860,866 | ||||||||||
| EIMEA | 480,483 | 235,922 | 305,482 | - | 1,021,887 | |||||||||||||||
| Asia Pacific | 205,190 | 357,602 | 65,389 | - | 628,181 | |||||||||||||||
| $ | 1,607,607 | $ | 973,012 | $ | 777,518 | $ | 152,797 | $ | 3,510,934 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Jan 22, 2026 | Showing above |
| 2024 | Jan 23, 2025 | |
| 2023 | Jan 24, 2024 | |
| 2022 | Jan 24, 2023 | |
| 2021 | Jan 25, 2022 | |
| 2020 | Jan 26, 2021 | |
| 2019 | Jan 24, 2020 | |
| 2018 | Jan 28, 2019 | |
| 2017 | Jan 31, 2018 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.